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Abstract 
Background: In our previous study, the extract of Trachyspermum copticum (L.) Link seeds on gene expression of 
IFN-γ and TGF-β1 in mouse model with irritant contact dermatitis (ICD), in comparison with cutaneous 
corticosteroids were evaluated. In that study, in addition to significantly increase of IFN-γ and TGF-β1 genes 
expression levels in skin samples of "mice with ICD" groups treated with extract in comparison to other groups, 
histopathologic findings showed substantial improvement of skin color, texture and thickness, and also significant 
increase in hair follicle number. Therefore, we have decided to study the levels of Interleukin-1 (IL-1) gene 
expression, which plays a major role in inflammation responses, and Keratinocyte Growth Factor/Fibroblast Growth 
Factor-7 (KGF/FGF-7), which has growth effect on cells and is an important endogenous mediator of hair follicle 
growth and development.   
Materials and Methods: We used autopsy samples of skin lesions obtained from "mice model with irritant contact 
dermatitis (ICD)" from the previous study. In that study, "mice with ICD" divided in 9 groups and were treated with 
three concentrations of Trachyspermum Copticum (L.) Link dried seeds, cutaneous hydrocortisone, and fluocinolone 
acetonide. Then from the first day until the 10th day of treatment, clinical signs and histopathologic investigations 
were investigated. In the present study, using Real-Time PCR, the levels of IL-1 and KGF/FGF-7 genes expression 
in skin samples of inflammation site in above mice groups were studied. Statistical analysis, using one -way 
ANOVA, were performed. Level of significance was set at 0.05. 
Results: The IL-1 gene expression showed a significant difference between groups: IL-1 gene expression levels in 
mice with ICD treated with extract and corticosteroids were higher than the other groups (p=0.0001). While in 
untreated "mice with ICD", no significant differences were observed. Also, during the treatment, there was a 
considerable increase in levels of IL-1 gene expression in groups treated with the extract at a rate of at least 2 to 3-
fold in comparison with the "healthy untreated mice" group. The levels of KGF/FGF-7 gene expression in "mice 
with ICD" groups treated with the extract showed significance difference (p=0.014); also there was a meaningful 
difference in "mice with ICD" groups treated with cutaneous corticosteroids (p=0.004). While, in "untreated mice 
with ICD" group there were a significant decrease in the levels of KGF/FGF-7 gene expression in comparison with 
"healthy untreated mice" group (p=0.0001). Also, changes in the levels IL-1 and KGF/FGF-7 gene expressions in 
each group in different days were seen. 
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Conclusion: In this study, significant changes in the IL-1 and KGF/FGF-7 genes expression levels in the skin 
samples with inflammation, were associated with an increase in the rate and speed of improvement of contact 
dermatitis, more favorable conditions of the healed skin (in terms of color, consistency, and thickness), and a 
remarkable increase in the number of hair grown on the site of dermatitis (compared with control groups, and even 
groups with corticosteroid therapy). 
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Introduction 
Contact dermatitis is inflammation of the skin, as a 
result of exposure to an exogenous agent, and 
constitutes a significant portion of occupational 
disorders in industrialized societies. Contact 
dermatitis is divided into irritant contact dermatitis 
and allergic contact dermatitis, based on their 
mechanistic differences: Irritant contact dermatitis 
(ICD) is caused by direct tissue damage following a 
single exposure or multiple exposures to an irritant 
while allergic contact dermatitis (ACD) is a delayed 
(type IV) hypersensitivity reaction, mediated by T 
cells and requiring prior sensitization1.  
Contact irritants in the workplace, are one of the 
causes of the dermatitis. Importance of the disease 
will be determined according to the International 
Labor Organization in 2010, which rates it as the 
second important of all occupational skin diseases 
that cause job disorders. In addition, it has been 
suggested to be rated as the first skin disease causing 
job disorder and is considered as a major health 
problem1. Irritant contact dermatitis (ICD) is an 
inflammatory response of the skin to various external 
stimuli. It arises because of activated innate 
immunity to direct injury of the skin without prior 
sensitization2-4. To treat dermatitis, various 
pharmacological groups used but corticosteroids 
considered as the main group. But these drugs in all 
cases, not only do not have sufficient efficacy but 
also long-term use of these drugs (due to the nature 
and type of the disease), has side effects, so 
researches to find new drugs with greater efficacy 
and fewer side effects continues. Studies have shown 
some of the herb’s healing effects on the inflammation 
of the skin and wounds. In this regard, the 
effectiveness of materials such as olive tree extract in 
healing of skin wounds in rats were evaluated and 
confirmed5. An annual plant that grows in Iran that is 
called Trachyspermum copticum L. link, traditionally 
were used as diuretic, carminative, and antihelmentic6. 
Some biological effects of ajowan such as antiviral7, 
anti-inflammatory8, antifungal9, antipyretic10, 
antifilarial11, analgesic12,13, antinociceptive14 and 
antioxidant activity15 have been confirmed. 
Malekpour et al, studied the effects of aqueous extract 
of Trachyspermum copticum (L.) Link seeds on levels 
of IFN-γ and TGF-β1 genes expression in mouse 
model with irritant contact dermatitis (ICD), in 
comparison with cutaneous corticosteroids as well as 
its effect on healing process. In that study, in addition 
to significantly increase of IFN-γ and TGF-β1 genes 
expression levels in skin samples of "mice with ICD" 
groups treated with extract in comparison to other 
groups, clinical and histopathologic findings showed 
substantial improvement of skin color, texture and 
thickness, and also significant increase in hair follicle 
number16. 
In this study, we planned additional investigations on 
aqueous extracts non-cytotoxic concentrations in 
experimental contact dermatitis mouse model. 
Considering that in the process of contact dermatitis, 
immune cells involved in tissue location can be 
influenced by factors such as cytokines and growth 
factors and there may be changes may be changes in 
tissue inflammation by Trachyspermum copticum L. 
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link extract contacted with the tissue in different 
concentrations. Thus, the macroscopic and 
microscopicchanges in tissue, as well as changes in 
gene expression of these cytokines can be a result of 
treatment of tissue with extract. 
Actually, we decided to study the gene expression of 
interleukin-1 (IL-1), which plays a major role in 
inflammation responses. Its role proved in ICD17,18. 
Keratinocyte Growth Factor/Fibroblast Growth 
Factor-7 (KGF/FGF-7), which is mitogenic, cell 
survival, cell growth, morphogenesis, tissue repair, 
tumor growth, and invasion activities is an important 
endogenous mediator of hair follicle growth, 
development, and differentiation18-23. 
Methods 
We used post-mortem samples of mice skin lesions 
with ICD from study of Malekpour et al,16. In that 
study, 3 weeks female BALB/c mice were divided 
into 9 groups: healthy control group (n=6), healthy 
controls treated with the solvent (used for the 
solution of the DNCB that is a solution of 4:1 
acetone and olive oil) (n=6), control group with ICD 
without treatment (n=6), control group with ICD 
treated with distilled water (n=6), mice with ICD 
treated with concentrations of 200, 1000 and 7000 
µg/mL of dried seed aqueous extract of 
Trachyspermum copticum (L.) Link (each group: 
n=10), mice with ICD treated with cutaneous 
hydrocortisone (n=6) and fluocinolone acetonide 
(n=6), 4 times a day. During the study, all clinical, 
macroscopic, and microscopic changes in mice were 
examined and monitored.  
After a duration of 10 days of treatment and 
humanely killing of mice, autopsy skin samples were 
prepared and ICD were confirmed by 
histopathological examination [hematoxylin and 
eosin (H&E) staining] and comparing the results with 
clinical signs.  
Real-Time PCR: The expression of IL-1 and 
KGF/FGF-7 genes, and GAPDH (as a housekeeping 
gene) in skin samples of the lesions after RNA 
extraction and cDNA synthesis were measured using 
Real-Time PCR. 
Statistical analysis: We performed statistical 
analysis, using one-way ANOVA. Level of 
significance was set at 0.05. 
Results 
You can find groups orientation and interventions in 
Malekpour et al, study16. 
IL-1 gene expression: The IL-1 gene expression 
showed a significant difference between groups: IL-1 
gene expression levels in mice with ICD treated with 
extract and corticosteroids were higher than the other 
groups (p=0.0001). While in untreated mice with ICD, 
no significant differences were observed. In addition, 
during the treatment, there was a considerable increase 
in levels of IL-1 gene expression in groups treated 
with the extract in the rate of at least 2 to 3-fold in 
comparison with the healthy untreated mice group 
(Figure 1a). 
KGF/FGF-7 gene expression: The levels of 
KGF/FGF-7 gene expression in mice with ICD groups 
treated with the extract showed significance difference 
(p=0.014); also there was a meaningful difference in 
mice with ICD groups treated with cutaneous 
corticosteroids (p=0.004). While, in "untreated mice 
with ICD" group there were a significant decrease in 
the levels of KGF/FGF-7 gene expression in 
comparison with healthy untreated mice group 
(p=0.0001). In addition, changes were seen in the 
levels of IL-1 and KGF/FGF-7 gene expressions in 
each group in different days (Figure 1b).  
Discussion 
Untreated mice with ICD group: Skin samples of 
untreated mice with ICD group showed an increased in 
the levels of IL-1 gene expression on the second to the 
6th day of treatment phase, and then, its expression was 
reduced; so that from the 7th to the 10th day of 
treatment phase, the levels of IL-1 gene expression 
were lower than its expression in the skin samples of 
healthy untreated mice group (almost the half). These 
are some commonly expected changes in an 
inflammation period (first phase: inflammation and 
tissue damage, and the second phase: tissue repair and 
healing). 
In addition, its elevation peak was on the 4th day of 
inflammation, about 1.5-fold in comparison with that 
of healthy untreated mice group.  
On the other hand, at the first days of treatment phase, 
the KGF/FGF-7 gene expression levels in the skin 
samples of untreated mice with ICD was about 0.3 of 
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its expression in healthy untreated mice group, and 
then with decreasing inflammation and gradual 
healing of the tissue (as detailed reported in study of 
Malekpour et al16), its levels gradually increased; so 
that on the 10th day of treatment phase, a 1.5-fold 
increase in its expression in the healthy untreated 
mice group were seen. 
Regarding the above mentioned findings, it seems 
that in the skin samples of untreated mice with ICD, 
the following changes are associated with an 
inflammatory state: multifold increase in levels of 
IL-1 gene expression; and a significant decrease in 
the levels of KGF/FGF-7 gene expression in the early 
days of treatment phase and an increase in its 
expression in the end days of the treatment phase 
(i.e., recovery period of the inflammation). 
Report of Malekpour et al16 on the clinical and 
histopathologic status of the skin of the untreated mice 
with ICD group at the end of the ten-day treatment 
phase, suggesting that, despite the clinical signs of 
inflammation reported in the skin samples of untreated 
mice with ICD, the appearance of the skin was thin 
and fragile, and the number of raised hair was very 
small. Also appearance of the hair was thin and fragile 
(poor quality and quantity of hair).  
It seems that the above mentioned changes in the 
levels of IL-1 and KGF/FGF-7 genes expression are a 
part of the molecular and microenvironment 
conditions of the skin in the mice with ICD: 
Mice with ICD, treated with Distilled water group: 
Levels of IL-1 and KGF/FGF-7 in the skin samples of 
this group showed a relatively similar changes to the 
untreated mice with ICD group. This results also 
indicates that the use of water for treatment of ICD in 
 
 
Figure 1. Changes in the levels of IL-1(a) and KGF/FGF-7(b) gene expression during treatment phase. 
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these mice did not change the levels of IL-1 and 
KGF/FGF-7 gene expressions; and also, according to 
the clinical quality of the skin of the mice and their 
histopathologic status, as reported by Malekpour et 
al16., had no effect on the reduction of dermatitis and 
tissue healing. 
The above observations provide the expected overall 
format of changes in the IL-1 and KGF/FGF-7 gene 
expressions in the skin samples obtained from mice 
with ICD in this study. 
Mice with ICD group treated with extract: The 
levels of IL-1 and KGF-FGF-7 genes expression in 
the skin samples of mice with ICD treated with 
different concentrations of the aqueous extract of 
Trachyspermum Copticum (L.) Link dried seeds were 
accompanied with considerable changes compared to 
their expression in the skin of "healthy untreated 
mice" and it could be said that largely, it followed a 
particular pattern. These changes were as follows: 
- In mice treated at a concentration of 200 μg/mL of 
extract, gradual increase in the levels of IL-1 gene 
expression continued until the 8th day of treatment 
phase was observed, and on the 8th day of treatment, 
levels of the gene expression reached to more than 4-
fold of its expression in the sample skins of healthy 
untreated mice group. The levels of gene expression 
on the last day of treatment (on the day 10) was also 
slightly less than 4-fold of the amount expressed in 
the skin samples of healthy untreated mice group. 
- In mice treated with a concentration of 1000 μg/mL 
of the extract, on the 4th day of treatment phase, an 
increase in levels of IL-1 gene expression was 
observed at a rate of 6.5-fold of that of the "healthy 
untreated mice" group.  
On the 6th day of treatment phase, a drop in the 
expression of this gene made it about 2.5-fold as 
much as expressed in the skin of "healthy untreated 
mice" group. 
On the 8th day of treatment phase, again, an increase 
in the levels of IL-1 gene expression was observed at 
5 times that of its expression in "healthy untreated 
mice" group; and on the 10th day, while the levels of 
gene expression decreased, but its expression was 3-
fold of its expression in skin samples of healthy 
untreated mice group. 
- In mice with ICD, treated at a concentration of 
7000 μg/mL, an increase in the levels of IL-1 gene 
expression was observed: on the 4th day of treatment 
phase, it was 6.5-fold greater than that of the "healthy 
untreated mice". This was similar to the observed IL-1 
gene expression levels in the skin samples of "mice 
with ICD" treated with a concentration of 1000 μg/mL 
of extract.  
Subsequently, the levels of IL-1 gene expression 
showed a decrease, and on the 6th day it was about 2.5-
fold of that of the healthy untreated mice group; which 
was similar to that of the mice with ICD" group 
treated with a concentration of 1000 μg/mL of extract.  
After the 6th day of treatment phase, the level of IL-1 
gene expression continued to decrease, but less rapidly 
than the interval between treatment days 4th and 6th. 
On the 10th day of treatment phase, its expression was 
approximately the same as the expression of this gene 
in the skin samples of healthy untreated mice group. 
After the 6th day of treatment phase, the levels of IL-1 
gene expression continued to decrease, but less rapidly 
than the interval between treatment days of 4th and 6th. 
On the 10th day of treatment, its expression was 
approximately the same as the expression of this gene 
in the skin samples of healthy untreated mice group. 
The study of the clinical and histopathologic findings 
of skin samples reported in the study by Malekpour et 
al showed that the above mentioned changes were 
accompanied by a completely improved clinical 
presentation and also a suitable histopathologic 
condition at the end of the 10th day of treatment phase; 
although increased concentrations of the extract were 
associated by better quality of the healing tissue and 
the raised hair (both in terms of appearance and 
number of hair).  
In mice with ICD group treated with extract, it seems 
that there is an association between increase in the 
levels of IL-1 gene expression in the first half of the 
course of treatment, and its reduction in the second 
half of the treatment phase, with the presence and 
activity of this cytokine in two stages of inflammation 
(i.e., initial and secondary phase). In other words, 
increasing the levels of IL-1 gene expression and, 
subsequently, the possible increase in IL-1 cytokines, 
triggers inflammatory and defensive reactions in the 
damaged tissue, and then, decreasing the levels of its 
expression; and subsequently reducing its potential 
concentration, leads to removing the inflammation and 
healing the tissue. The clinical and histopathologic 
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observations performed on the skin sample of mice 
(reported in study of Malekpour et al16) are consistent 
with these findings. 
In general, study of levels of gene expression in skin 
samples of "mice with ICD" treated with different 
concentrations of the aqueous extract, regardless of 
the concentrations of extract, showed similar changes 
in the levels of IL-1 gene expression, and the clinical 
and reported histopathological conditions of the skin. 
These similar changes were as follows: 
• Considerable differences in levels of IL-1 gene 
expression (severalfold increase, in comparison with 
the expression in "untreated healthy mice" group; 
• A severalfold increase in the levels of IL-1 gene 
expression, which has been noticeable from the 4th 
day of the treatment period. 
• High rate of elimination of inflammation and 
healing of the skin samples (reported in study of 
Malekpour et al16) in comparison with the control 
groups and groups treated with cutaneous 
corticosteroids; 
• Highly desirable skin quality and a large number of 
hair follicles (observed in clinical and 
histopathologic examinations). Although the increase 
in the quality and number of hair follicles was 
associated with increasing the concentration of the 
extract); 
Also, there were some differences among the levels 
of IL-1 gene expression in the skin samples of "mice 
with ICD" treated with different concentrations of the 
extract, as follows: 
Although levels of IL-1 gene expression increased 
dramatically in some days in "mice with ICD" groups 
treated with extract with a relatively similar pattern, 
but in the treated group at a concentration of 
1000 μg/mL, a decreased levels of IL-1 gene 
expression on the 6th day of the treatment, and again 
an increased levels of IL-1 gene expression by up to 
5-fold of its expression in the sample of skins of 
heathy untreated mice group were observed. This 
difference in the fluctuation in levels of IL-1 gene 
expression in "mice with ICD" groups treated with 
different concentrations of the extract can be due to: 
• Different effects of different concentrations on the 
levels of gene expression due to changing in amount 
and concentrations of extract components; 
• Experimental error; 
• The necessity of examining the gene expression in 
more samples and lower time intervals; 
On the other hand, changes in levels of KGF/FGF-7 
gene expression in mice with ICD treated with 
different concentrations of the extract (200, 1000, and 
7000 μg/mL of extract), showed a relatively similar 
pattern of changes in KGF/FGF-7 gene expression in 
these three groups; i.e.: Inflammation in the skin of the 
mice has been associated with a high reduction in the 
levels of expression of this gene (about 0.2 of its 
expression in the skin samples of healthy untreated 
mice group), and after a gradual increase and decrease 
in its expression (around the 6th to 8th day), a peak is 
observed in the expression of this gene, which has 
reached its expression to about 0.6 to 0.8 that of its 
expression in the skin samples of the healthy untreated 
mice group; but its expression has never reached to 
that of its expression in this group. In fact, its 
expression at the end of the 10th day of treatment, was 
at a maximum of 0.4 of its expression in the skin 
samples of "healthy untreated mice" group. 
Comparing the clinical and histopathologic conditions 
reported in Malekpour et al with the above mentioned 
results, suggests that increasing the speed of tissue 
healing and reduction of inflammation, have been 
associated with gradually increasing levels of 
KGF/FGF-7 gene expression and then its reduction in 
the final days of treatment. It is noticeable that during 
the 10 days of treatment period, the levels of 
KGF/FGF-7 gene expression has never reached to its 
expression in the skin sample obtained from the 
healthy untreated mice group. 
In general, it can be said that a healthy, non-
inflammatory, and healed skin from 6th to 10th days of 
treatment with extract in the study of Malekpour et al16 
indicates that the treatment of skin of mice with ICD 
with extract had a significant effect on the speed and 
quality of the healing process and removing the 
inflammatory condition of the skin, as well as the 
quality and quantity of the raised hair.  
It seems that a high increase in the levels of IL-1 gene 
expression in the first half of the inflammatory process 
and the gradual increase in KGF/FGF-7 gene 
expression during treatment, and reaching to about 
1.5-fold of its level of expression in the health status, 
is associated with a faster and higher quality of the 
process of removing the inflammation, healing the 
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skin, and the quality and quantity of raised hair, 
though in a gradual and upward trend. 
Therefore, it can be argued that if a drug can provide 
such an alteration in levels of IL-1 and KGF/FGF-7 
gene expression, it can be effective in healing and 
improving the cutaneous inflammation and 
increasing the quality and quantity of raised hair. 
Considering the role of KGF/FGF-7 in processes 
such as cell growth and tissue regeneration, a gradual 
increase in the expression of this gene in this group 
of mice is expected and suggests that the induction of 
ICD in mice has been associated with a change in the 
expression of this gene involved in the process of 
inflammation and tissue healing. However, it seems 
that an increase more than that observed in the "mice 
with ICD" groups treated with extract, has not had a 
positive effect on the removing of inflammation, and 
tissue repair in other groups. 
Mice with ICD treated with cutaneous 
corticosteroids: In the "Mice with ICD" group 
treated with cutaneous hydrocortisone, a rapid initial 
increase in levels of IL-1 gene expression was 
observed; so that on the second day of treatment 
phase, the expression rate was 6-fold, and on the 6th 
day it was more than 10-fold of its expression in the 
"healthy untreated mice". Then, with a gradual 
reduction trend, its expression on the 10th day of 
treatment phase was 3-fold higher than its in "healthy 
untreated mice" group. It seems that changes in the 
expression of this gene under the influence of 
treatment with cutaneous hydrocortisone follow the 
same pattern of expression changes in mice with ICD 
groups treated with the extract, with the exception 
that its initial rate of increase is much higher than 
that of the treated groups with extract is. 
Also, treatment of the mice with ICD group with 
cutaneous hydrocortisone was associated with a rapid 
increase in levels of KGF/FGF-7 gene expression: its 
gene expression on the 4th day of treatment phase 
showed a 4.5-fold increase in comparison with its 
expression in the healthy untreated mice group, and 
then its expression declined slightly below its levels 
of that of the health status. While in mice with ICD 
groups treated with different concentrations of 
extract, although there was an increase and a 
decrease in the expression of this gene, but its 
expression was always lower than the health status. 
In the mice with ICD group treated with fluocinolone 
topical, a rapid initial increase in levels of IL-1 gene 
expression was observed (similar to that of 
hydrocortisone-treated group), so that on the second 
day of treatment phase, the gene expression rate was 
5.5-fold and on the 6th day, it showed about 7.8-fold 
increase in comparison with its expression in the 
healthy status. Then, with a gradual decline, its 
expression on the 10th day of treatment phase showed 
a 4-fold increase in comparison with the healthy 
status. It seems that changes in the levels of expression 
of this gene in group treated with topical fluocinolone 
were very similar to the changes observed in the mice 
treated with cutaneous hydrocortisone. Also it 
followed the same pattern of changes in levels of gene 
expression in mice with ICD groups treated with three 
different concentrations of extract; with the difference 
that its initial increasing rate was much higher than 
that of the groups treated with the extract.  
In addition, treatment of mice with cutaneous 
hydrocortisone was associated with fluctuations in the 
KGF/FGF-7 gene expression levels. However, the 
direction of these fluctuations was toward to an 
increase in the expression of this gene, so that on the 
10th day of treatment phase, its expression showed 
about 3-fold increase in comparison with that in the 
health status. While in mice treated with different 
concentrations of the extract, there was an increase 
and decrease in expression levels of this gene, but 
levels were lower than that in the healthy status at all 
times. 
The report of Malekpour et al on the apparent and 
histopathologic conditions of the skin of the mice in 
the two groups treated with cutaneous corticosteroids 
suggests that, although at the end of the 10th day of 
treatment phase, the skins were completely treated, but 
they were thin and the raised hair was low and fragile. 
In addition, in terms of quantity and quality, they did 
not show the favorable conditions of the "mice with 
ICD" groups treated with extract. 
It seems that the pattern of IL-1 and KGF/FGF-7 
genes expression levels in the skin samples obtained 
from the "mice with ICD" groups treated with three 
concentrations of the aqueous extract of 
Trachyspermum copticum (L.) Link Seeds, especially 
the concentration of 7000μg/mL, were the best 
possible state for the treatment of mice model of 
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irritant contact dermatitis. 
Conclusion 
Investigating the changes in the IL-1 and KGF/FGF-
7 genes expression levels in the skin from mice 
model of irritant contact dermatitis and comparing 
them with clinical evidence and histopathologic 
findings reported in study of Malekpour et al, 
showed the promising effects of aqueous extract of 
Trachyspermum copticum (L.) Link Seeds in 
treatment of skin in these mice. In fact, in this study, 
significant changes in the IL-1 and KGF/FGF-7 
genes expression levels in the skin samples with 
inflammation, were associated with an increase in the 
rate and speed of improvement of contact dermatitis, 
more favorable conditions of the healed skin (in 
terms of color, consistency, and thickness), and a 
remarkable increase in the number of hair grown on 
the site of dermatitis (compared with control groups, 
and even groups with corticosteroid therapy). 
A thorough and comprehensive molecular, clinical 
and histopathological study of anti-inflammatory and 
healing effect mechanisms of aqueous extract of 
Trachyspermum copticum (L.) Link Seeds and the 
relationship between changes in the expression of 
genes associated with inflammation, healing, and hair 
growth, including IL-1 and KGF/FGF-7 cytokines, is 
suggested. Also, given that the Trachyspermum 
copticum (L.) Link Seeds is used in traditional 
medicine in countries such as Iran, India, and Egypt, 
a clinical trial to investigate the anti-inflammatory 
and healing effects of this extract on the irritant 
contact dermatitis in human is suggested. 
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